Proactive - Interviews for investors

Proactive - Interviews for investors

Download on the App Store

Proactive - Interviews for investors episodes

  • Helix Exploration Reaches total depth in Darwin #1 Well, Reveals High Helium Concentrations
    Helix Exploration CEO Bo Sears joined Steve Darling from Proactive to announce the completion of the Darwin #1 well drilling at the Rudyard project area in Montana, where they reached a total depth of 5,488 feet within 12 days. Initial assessments showed promising helium gas-shows across multiple horizons, with concentrations reaching up to 1,312 ppm in drilling mud.
    Over 330 feet of potential gross pay was identified, including untapped formations not covered in historic drilling. The results indicate a larger anticline structure than initially modeled, as the target horizons came in higher than predicted. Sears noted that Darwin #1 appears to have been drilled near the apex of a more extensive domal anticline, suggesting a broader closure extent for the reservoir.
    Helix now plans to perform wireline logging at Darwin #1 to define specific zones for perforation and testing. The company is concurrently testing another well, Ingomar, marking a notably active phase for Helix. Additionally, ongoing testing at Clink #1 is set to reveal first gas analysis results soon, providing further insights into the company’s Montana exploration potential.
    #proactiveinvestors #helixexplorationplc #aim #hex #HeLIXExploration #EnergyUpdate #HeliumMarket #HydrogenExploration #KlinkWell #NaturalGas #ChipManufacturing #ProactiveInterview
    #HeliumDrilling #MontanaHelium #BoSears #HeliumExploration #EnergySector #CHIPSAct #DarwinWell #HeliumIndustry #ProactiveInvestors
    #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    3 min
  • Chemomab Therapeutics CEO Dr Adi Mor discusses Q3 results; progress with lead PSC treatment
    Chemomab Therapeutics CEO Dr Adi Mor talked with Proactive's Stephen Gunnion about recent advancements in Chemomab's mission to treat rare fibrotic diseases, focusing on primary sclerosing cholangitis (PSC).
    Following the release of the company's third-quarter results, Mor shared that Chemomab’s lead candidate, CM-101, a drug targeting inflammation and fibrosis, recently delivered positive topline results in a Phase 2 clinical trial. “We are targeting rare diseases with large commercial potential and high unmet medical need,” he noted, highlighting Chemomab's strategic approach.
    In a significant milestone, Chemomab will meet with the FDA by the end of this year to finalise plans for a Phase 3 pivotal study, which could mark a transformative phase for the company and the PSC treatment landscape. Mor pointed out the potential for FDA acceptance of noninvasive biomarkers as registration endpoints, indicating substantial de-risking for CM-101. She also shared updates on Chemomab’s extended study on PSC, expected to deliver additional data by Q1 2025.
    Mor highlighted the commercial potential in treating PSC, noting there are no approved drugs for this condition that affects approximately 80,000 patients in major markets. Additionally, Chemomab recently raised $10 million, securing its financial runway into 2026, aided by support from top-tier investors like OrbiMed and new partners such as HBM Partners and Sphera. This capital will fund upcoming milestones, as well as further development for CM-101.
    Stay tuned to Proactive’s channel for more insights into Chemomab Therapeutics, and don’t forget to like, subscribe, and enable notifications for future updates!
    #ChemomabTherapeutics #AdiMor #PSC #CM101 #FibroticDiseases #FDAApproval #ClinicalTrials #RareDiseaseTreatment #LiverDisease #Biotech #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    6 min
  • Far East Gold delivers maiden 540,000-ounce resource at Idenburg
    Far East Gold Ltd (ASX:FEG, OTC:FEGDF). CEO Shane Menere joins Proactive’s Tylah Tully to discuss the company’s latest milestone.
    It has delivered an initial JORC 2012 inferred mineral resource estimate of 540,000 ounces of gold at 4.1 g/t and 468,000 ounces of silver at 3.6 g/t at its Idenburg Project in Papua, Indonesia.
    This estimate, based on just three prospects within the Idenburg Contract of Work was developed by SMG Consulting using historical drill hole data and new topographic survey information without additional drilling.
    The prospects contributing to this estimate — Sua, Bermol and Mafi — are three of the 14 targets identified, covering only 30% of the project area, leaving substantial potential for future exploration.
    SMGC conducted a comprehensive review, modelling mineralisation based on geological continuity and grade using inverse distance weighting (IDW) for Sua and Mafi.
    FEG aims to expand the initial resource through surface mapping, sampling and a phase 1 drilling program.
    Future exploration will include infill and step-out drilling, metallurgical sampling and geophysical surveys to enhance resource delineation.
    The Idenburg Project benefits from good infrastructure and access via the Trans Irian Highway, offering efficient logistical support.
    More information can be found in a video discussing the update on FEG’s investor hub.
    #ProactiveInvestors #FarEastGold #ASX #GoldExploration, #IdenburgProject, #PapuaGold, #Mining, #MineralResources, #JORCCode, #InferredResources, #SilverMining, #ExplorationTargets, #SuaProspect, #BermolProspect, #MafiProspect, #Phase1Drilling, #TopographicSurvey, #SMGConsulting, #PapuaIndonesia, #MiningUpdates, #ResourceEstimate, #Gold
    5 min
  • Inside Scout Security’s strategic Roo acquisition
    Scout Security Ltd (ASX:SCT) CEO and executive director Ryan McCall talks with Proactive’s Tylah Tully about the company’s latest strategic move: a merger with Roo Inc., a fellow DIY home security company.
    McCall outlined the mutual benefits of this merger, which will combine the companies’ strengths in the DIY security and smart home markets, enhancing scale and efficiency.
    Scout Security, initially a direct-to-consumer business, has pivoted toward white-label partnerships, delivering custom solutions to telecommunications companies, ISPs and security providers.
    By merging with Roo, Scout aims to leverage economies of scale and increase cash flow.
    “What it means is you’re taking two smaller but similar companies … combining them and then gaining a lot of economies of scale,” McCall explained, noting that Roo’s consumer retail experience complemented Scout’s white-label strategy.
    The merger is designed to create new revenue streams by rolling up smaller security and IoT companies.
    McCall highlighted this approach as a way to compete with larger industry players by building a scalable entity that can deliver valuable products and reliable returns.
    Investors will also note the strategic financial positioning, including a recapitalisation that McCall said positioned the stock price advantageously.
    #ProactiveInvestors #ScoutSecurity #ASX #RooInc #HomeSecurity #DIYSecurity #ASXSCT #RyanMcCall #Merger #SmartHome #InvestorUpdate #ProactiveInvestors #CashFlow
    8 min
  • Groundbreaking cancer trial: Imugene’s CF33 advances in clinical success
    Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong and Professor Yuman Fong, chair of the Department of Surgery at the City of Hope and strategic advisor to Imugene, spoke with Proactive’s Tylah Tully about the latest developments in Imugene’s CF33 MAST (Metastatic Advanced Solid Tumours) VAXINIA study.
    Professor Fong, the inventor of CF33, described the approach behind the therapy, where genetically engineered viruses are designed to infect and kill cancer cells without harming normal cells.
    “In our lab, we prioritized creating a virus that could kill cancer of various types while remaining safe for humans,” he noted, explaining that this latest generation of the CF33 virus has shown positive results across a broad range of cancers, including melanoma and bile duct cancer.
    Chong and Professor Fong discussed the ongoing trials, where Imugene has received FDA orphan drug status and is seeing promising tumour responses in patients with advanced-stage cancers, including the challenging bile duct cancer.
    Chong highlighted the stability achieved in patients participating in the trial, some of whom previously exhausted other treatments.
    She explained, “Even at low doses, we’re seeing disease stabilization, which is remarkable given that these patients have been through multiple other therapies before coming to us.”
    As CF33’s clinical trials continue, Chong and Professor Fong are optimistic about the potential to offer a new option for patients with difficult-to-treat cancers.
    With the backing of a strong clinical and manufacturing team, Imugene is now expanding the trial to additional patients and combining CF33 with CD19-targeting drugs to further evaluate its impact on immune response and tumor reduction.
    #ProactiveInvestors #Imugene #ASX #CancerResearch #CF33 #OncolyticVirus #CancerTreatment #VAXINIA #ClinicalTrials #Immunotherapy #CancerInnovation #MetastaticCancer #ProactiveUpdates #LeslieChong #YumanFong #FDAApproval #OrphanDrugStatus #CancerScience
    16 min
  • Just the Facts: Astral Resources reveals gold grades up to 63.4 g/t
    Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Astral Resources NL (ASX:AAR).
    The company has received high-grade gold intercepts from the final 11 drill holes at its Kamperman Deposit, part of the Feysville Gold Project in Western Australia.
    The reverse circulation (RC) drilling campaign comprised 31 holes, revealing significant gold intersections that reinforce the site’s resource potential.
    Key results include an intercept of 6 metres at 12.8 g/t gold from 76 metres, with a high-grade segment of 1 metre at 63.4 g/t. Other notable results included 33 metres at 3.75 g/t from 58 metres and 22 metres at 5.21 g/t from 149 metres.
    These findings are expected to strengthen Astral’s geological models and validate its infill drilling approach.
    The results were not included in the maiden mineral resource estimate (MRE) for Kamperman, announced on November 1, of 2 million tonnes at 1.3 g/t gold for 83,800 ounces of contained gold.
    Astral intends to incorporate these new results to expand the MRE.
    Following the Kamperman program, the RC drill rig has moved to the Mandilla Gold Project. Initial diamond drilling at Mandilla’s Theia deposit has shown visible gold, with assay results expected in early 2025.
    #ProactiveInvestors #AstralResources, #ASX #JusttheFacts #GoldExploration, #KampermanDeposit, #FeysvilleProject, #WesternAustralia, #GoldMining, #HighGradeGold, #DrillResults, #ResourceExpansion, #MandillaGoldProject, #VisibleGold, #DiamondDrilling, #MiningNews, #Geology, #InfillDrilling, #ASXAAR, #MineralExploration, #GoldAssays, #AustralianMining, #GoldPotential
    2 min
  • Navarre Minerals resumes ASX trading with gold focus
    Navarre Minerals Ltd (ASX:NML) managing director and executive chair James Gurry talks with Proactive’s Tylah Tully about the company's recent recapitalisation, ASX trading resumption and its renewed focus on high-grade gold exploration in Victoria.
    Following a strategic shift back to its core gold exploration roots, Navarre now prioritises advanced exploration across five primary projects, including the Tandarra, Irvine and St Arnaud projects.
    Gurry highlighted Navarre’s resource potential, noting that the company has defined approximately 700,000 ounces in gold resources, with a core focus on its Irvine project.
    "What you can expect is for us to get to work," Gurry stated, emphasising the company’s clean capital structure, its $6 million cash reserve and a renewed drilling strategy.
    The company plans an extensive, continuous 7,000-metre drilling campaign aimed at demonstrating strong project fundamentals to shareholders and investors over the next 12 months.
    The recapitalisation has returned Navarre to the market at a low valuation, a move intended to position the company advantageously for growth.
    Additionally, Gurry shared that the company would undergo a rebranding, adopting the new name Au-Reeka in December to reflect its refreshed vision and goals.
    #ProactiveInvestors #NavarreMinerals #GoldExploration #ASX #JamesGurry #VictoriaGold #MineralExploration #TandarraProject #StArnaudProject #GoldMining #InvestmentInsights #ProactiveInvestors #ASXUpdate #AuReeka
    9 min
  • Everything you need to know about AGM season: Jane Lowe explains
    IR Department’s managing director Jane Lowe talked with Proactive’s Tylah Tully about AGM season and the critical role annual general meetings play for shareholders and companies alike.
    Lowe highlighted the importance of AGMs as a platform for shareholder engagement, noting they offer shareholders a rare chance to vote on essential company matters and interact directly with the board and executive team.
    “The AGM can be an excellent platform for engaging with potential and existing shareholders,” Lowe explained, emphasizing the value of well-prepared resolutions and open communication.
    Lowe walked through the AGM process, from preparing resolutions and understanding shareholder preferences, to ensuring CEOs and board members are prepared for Q&A sessions.
    In addition, she highlighted the importance of shareholder attendance at AGMs, both for voicing support and raising concerns.
    AGMs also provide an opportunity for executives to present future goals and milestones, giving investors a clear sense of the company's upcoming objectives.
    With a busy AGM season and several IPOs in progress, Lowe’s expertise highlights her commitment to the evolving needs of the finance sector and investor relations.
    “We’re heads down on that right now,” she noted. The IR Department continues to support clients in managing successful AGMs, roadshows, and upcoming IPOs, with plans to attend the JP Morgan Healthcare Conference early next year.
    #ProactiveInvestprs #IRDepartment #ASX #AGM #AnnualGeneralMeeting #JaneLowe #InvestorRelations #ShareholderEngagement #FinanceSector #IPO #CorporateStrategy #ProactiveInvestors #IRDepartment
    9 min
  • Empire Metals has breakthrough titanium results at Pitfield
    Empire Metals Ltd (LON:EEE) managing director Shaun Bunn talked with Proactive’s Tylah Tully about metallurgical results from the Pitfield Titaniujm Project in Western Australia.
    Gravity and flotation test results show that Empire can successfully separate titanium minerals from other gangue materials, reducing potential downstream processing costs.
    "Simple gravity separation is getting rid of the silicates," Bunn noted, explaining the advantage of reducing complexities and costs in further refining stages.
    The metallurgical tests identified a high-purity titanium concentrate, with around 70-80% titanium recovered in initial tests.
    Bunn highlighted that these results were achieved through simple and low-cost gravity separation techniques.
    The success of these tests paves the way for the company to potentially develop a cost-effective pilot plant, marking a significant advancement in the project's progression.
    Bunn also mentioned that Empire Metals could potentially sell separated out iron oxide byproducts from titanium oxide, creating potential added value.
    The next phase will focus on refining the titanium concentrate further, aiming for a breakthrough in titanium extraction processes within the next few months.
    #ProactiveInvestors #EmpireMetals #LON #AIM #EEE #ShaunBunn #PitfieldProject #TitaniumMining #MetallurgicalTest #MiningAustralia #TitaniumExtraction #GravitySeparation #MiningIndustry #MineralProcessing
    7 min
  • Hive Digital Technologies reports jump in Q2 Revenue, expands Bitcoin and high-performance computing
    Hive Digital Technologies Chief Financial Officer Darcy Daubaras joined Steve Darling from Proactive to share news the company generated $22.6 million in revenue for Q2 2024, primarily from digital currency mining and high-performance computing (HPC) hosting services. The HPC sector has been a growing focus for Hive, now at an annualized run rate of $9.0 million, enhancing the company’s position in the HPC market.
    During the quarter, Hive successfully mined 340 Bitcoin, further bolstering its substantial digital asset holdings. As of September 30, the company held $165.2 million in digital assets, including 2,604 Bitcoin, aligning with its strategy to strengthen its HODL position. Using a Bitcoin price of $63,300 at quarter-end, Hive’s reserves have doubled over the past year.
    The company reported an Adjusted EBITDA of $5.6 million, signaling strong operational management and financial performance. Hive’s dedication to green energy use in digital currency mining also positions it favorably as global regulatory frameworks around digital assets become more supportive. Looking ahead, Hive aims to reach 2% of the global Bitcoin mining network by late 2025, reflecting its commitment to sustainable growth and leadership in the evolving digital asset industry.
    #proactiveinvestors #hivedigitaltechnologieslet #tsxv #hive #nasdaq #hive
    #BitcoinMining #Cryptocurrency #GreenEnergy #ParaguayExpansion #Blockchain #SustainableMining #CryptoNews #RenewableEnergy #Bitcoin#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    6 min

About Proactive - Interviews for investors

From the publisher's feed

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage.

More shows like Proactive - Interviews for investors

Autoline Daily by Autoline

Autoline Daily

80 Listeners

ev.news by Martyn Lee

ev.news

468 Listeners